Can a Common Virus Cause Brain Cancer? polyDNA Answers Survey Question and Recommends Gene-Eden-VIR and Novirin against the Latent Cytomegalovirus (CMV)

• 

We recommend that concerned individuals get a CMV blood test. If positive, they should talk to their doctors about Gene-Eden-VIR and Novirin. - Mike Evans, polyDNA

Rochester, NY (PRWEB) May 11, 2014

In polyDNA’s April 2014 survey, 24% of respondents wanted to know if a virus can cause brain cancer. The answer is yes. Research shows that the human cytomegalovirus (CMV) is found “in brain tumors in both adults (glioblastoma) and children (medulloblastoma).” (See Oncoimmunology, from August 1, 2012) (1). In fact, CMV is found in many cancers. “Other more common cancer forms such as breast cancer, colon and prostate cancer as well as salivary gland mucoepidermoid carcinomas are also frequently virus positive, with a prevalence approaching 90-100% (1).” polyDNA therefore recommends that concerned individuals ask their doctors for a blood test that tests for the presence of CMV. If positive, they should talk to the doctor about Gene-Eden-VIR and Novirin. The formula in these natural antivirals was clinically shown to reduce CMV symptoms, including fatigue, in two post-marketing clinical studies that followed FDA guidelines.

Scientists discovered that “CMV proteins are expressed only in tumor cells, while non-tumor cells surrounding the tumor are CMV negative (1).” Moreover, CMV causes “DNA damage and inhibits DNA repair mechanisms, induces oncogene expression and telomerase activity, induces inflammation and at the same time avoids recognition by the immune system (1).”

“The virus is generally passed from infected people to others through direct contact with body fluids, such as urine, saliva, or breast milk. CMV is sexually transmitted. It can also be spread through transplanted organs and blood transfusions. People who are infected with CMV can shed the virus (pass the virus from their infected body fluids, such as urine, saliva, blood, and semen, into the environment). Young children often shed CMV for months after they first become infected.” (See the CDC, last updated July 28, 2010) (2).

What can individuals do if they are infected with CMV?

“Several drugs are approved for the treatment of HCMV infections in immunocompromised individuals. These drugs include ganciclovir, its oral prodrug valganciclovir, cidofovir, foscavir and fomivirsen. However, the use of these drugs in immunocompetent individuals is limited by their toxicity, poor oral bioavailability, modest efficacy, and the development of drug resistance.” (See Pharmacology & Pharmacy, from September 2013) (3). In other words, the only drugs available are normally reserved for those who have a severely compromised immune system, such as those with HIV/AIDS. There are no drugs approved for those with a mostly healthy immune system.

In contrast, there are two natural antivirals with a formula that has been shown to reduce symptoms of a CMV infection in two separate post-marketing clinical studies. Those products are Gene-Eden-VIR and Novirin.

“We recommend that concerned individuals get a CMV blood test. If positive, they should talk to their doctors about Gene-Eden-VIR and Novirin. The formula of these natural antivirals was designed to help the immune system target the latent virus.” - Mike Evans, polyDNA

Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology (3).

Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

Up to 70% of those studied reported a decrease in symptoms associated with CMV infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (3).

Each ingredient of Gene-Eden-VIR and Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.

A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (4).

To learn more about Novirin, visit http://www.novirin.com and about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:    

(1) Cytomegalovirus infection in brain tumors. Published on August 1, 2012.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429578/

(2) CDC - Cytomegalovirus (CMV) and Congenital CMV Infection - Transmission. Last updated on July 28, 2010.
http://www.cdc.gov/CMV/transmission.html

(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(4) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014. http://www.cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.

PDF Print